This content is machine translated "Psoriasis and Beyond" Insight into the patient’s perspective In order to better understand the experiences and views of patients affected by psoriasis and psoriatic arthritis, a survey of almost 5,000 patients was conducted on four continents worldwide.One focus…
View Post 5 min This content is machine translated Rheumatoid arthritis Using predictors to improve therapy management A few years ago, the EULAR agreed on a definition for “difficult-to-treat” rheumatoid arthritis (RA).The reasons for multiple treatment failures are not yet fully understood. Research projects are trying to…
View Post 4 min This content is machine translated Clinical suspicion of Borrelia infection When is a serological clarification useful? The diagnosis of a Borrelia infection is not always easy. There are cases in which the symptoms are not initially associated with a tick bite or are atypical. Serological testing…
View Post 5 min This content is machine translated Osteoporosis How patients benefit most from osteoporosis therapeutics Osteoporosis therapeutics have been proven to be effective in reducing the risk of vertebral and non-vertebral fractures. Ideally, they should be used as part of a multimodal therapy and tailored…
View Post 3 min This content is machine translated Study report Back pain due to axial SpA? Axial spondyloarthritis (axSpA) is one of the most common inflammatory rheumatic diseases affecting the axial skeleton. Back pain and limited mobility in the lumbar spine are among the main symptoms.…
View Post 5 min This content is machine translated Sponsored Content: United European Gastroenterology Week (UEGW) 2023 Risankizumab demonstrates superiority compared to ustekinumab in Crohn’s disease [1] Data from the current SEQUENCE study was presented at the United European Gastroenterology Week (UEGW), which took place from October 14 to 17, 2023, and has since been published [1,2].…
View Post 5 min This content is machine translated Polymyalgia rheumatica and giant cell arteritis New consensus paper recommends “treat-to-target” strategy Giant cell arteritis and polymyalgia rheumatica are inflammatory rheumatic diseases that often occur together and almost exclusively affect people over the age of 50. Glucocorticoids are initially used for both…
View Post 5 min This content is machine translated Systemic lupus erythematosus DORIS and LLDAS are also worthwhile for severe cases DORIS (Definition of Remission in SLE) and LLDAS (Lupus Low Disease Activity State) are established measures of remission in systemic lupus erythematosus (SLE), but their feasibility and validity have not…
View Post 4 min This content is machine translated Casuistry SLE with kidney damage does not always have to be lupus nephritis The distinction between IgA nephropathy and lupus nephritis in patients with systemic lupus erythematosus (SLE) has important prognostic and therapeutic implications. Physicians from China describe a case of systemic lupus…
View Post 5 min This content is machine translated Rheumatoid arthritis JAK inhibitor reduces pain for a long time Patients with active rheumatoid arthritis often suffer from considerable pain. Therefore, pain control is an important treatment goal in this patient group. In a post-hoc analysis of the FINCH studies…
View Post 4 min This content is machine translated SLE: Early use of biologics? Findings from the “Leeds SLE Inception Cohort” If systemic lupus erythematosus (SLE) cannot be adequately controlled with hydroxychloroquine and cortisone preparations, the use of immunomodulatory or immunosuppressive agents and/or biologics should be considered according to current EULAR…
